These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32717309)

  • 1. Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers.
    Kanumuri R; Saravanan R; Pavithra V; Sundaram S; Rayala SK; Venkatraman G
    Gene; 2020 Nov; 760():144991. PubMed ID: 32717309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
    Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
    Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
    Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
    Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
    Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
    Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
    Parvathy M; Sreeja S; Kumar R; Pillai MR
    BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
    Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
    Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
    Yellapu NK; Pulaganti M; Pakala SB
    J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
    Tabusa H; Brooks T; Massey AJ
    Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling.
    Shrestha Y; Schafer EJ; Boehm JS; Thomas SR; He F; Du J; Wang S; Barretina J; Weir BA; Zhao JJ; Polyak K; Golub TR; Beroukhim R; Hahn WC
    Oncogene; 2012 Jul; 31(29):3397-408. PubMed ID: 22105362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.
    Ghosh A; Awasthi S; Peterson JR; Hamburger AW
    Br J Cancer; 2013 Feb; 108(3):557-63. PubMed ID: 23361053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of protein kinase PAK1 in the regulation of estrogen-independent growth of breast cancer].
    Avilova EA; Andreeva OE; Shatskaia VA; Krasil'nikov MA
    Biomed Khim; 2014; 60(3):322-31. PubMed ID: 25019394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21 activated kinase-1 and tamoxifen - A deadly nexus impacting breast cancer outcomes.
    Rajendran S; Swaroop SS; Roy J; Inemai E; Murugan S; Rayala SK; Venkatraman G
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188668. PubMed ID: 34896436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.
    Akinmade D; Talukder AH; Zhang Y; Luo WM; Kumar R; Hamburger AW
    Br J Cancer; 2008 Mar; 98(6):1132-40. PubMed ID: 18283314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.
    Prudnikova TY; Villamar-Cruz O; Rawat SJ; Cai KQ; Chernoff J
    Oncogene; 2016 Apr; 35(17):2178-85. PubMed ID: 26257058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.
    Huynh N; Liu KH; Baldwin GS; He H
    Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer.
    Li Q; Mullins SR; Sloane BF; Mattingly RR
    Neoplasia; 2008 Apr; 10(4):314-29. PubMed ID: 18392133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway.
    Jiao D; Zhang XD
    Oncol Rep; 2016 Jul; 36(1):342-8. PubMed ID: 27122002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer.
    Bostner J; Skoog L; Fornander T; Nordenskjöld B; Stål O
    Clin Cancer Res; 2010 Mar; 16(5):1624-33. PubMed ID: 20179234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.